PWM
WST icon

Parkworth Wealth Management’s West Pharmaceutical WST Stock Holding History

Parkworth Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$219 Hold
1
– – ﹤0.01% 919
2025
Q1 		$224 Hold
1
– – ﹤0.01% 691
2024
Q4 		$328 Buy
+1
New +$315 ﹤0.01% 580

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Parkworth Wealth Management's WST Position: Q2 2025 in Review

Parkworth Wealth Management held its West Pharmaceutical (WST) position steady in Q2 2025 at 1 share worth $219. The position accounts for ﹤0.01% of the portfolio, ranked #919.

Parkworth Wealth Management first reported a position in WST in Q4 2024 and has held it in 3 quarters since. The position peaked at $328 in Q4 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Parkworth Wealth Management held 1 share of West Pharmaceutical worth $219 as of Q2 2025.
  • Parkworth Wealth Management left its West Pharmaceutical share count unchanged in Q2 2025.
  • West Pharmaceutical made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #919 holding.
  • Parkworth Wealth Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's West Pharmaceutical position peaked at $328 in Q4 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.